These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 19647035)
1. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia. Kedees MH; Grigoryan M; Guz Y; Teitelman G Mol Cell Endocrinol; 2009 Nov; 311(1-2):69-76. PubMed ID: 19647035 [TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice. Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250 [TBL] [Abstract][Full Text] [Related]
3. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice. Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220 [TBL] [Abstract][Full Text] [Related]
4. Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice. Wei T; Cui X; Jiang Y; Wang K; Wang D; Li F; Lin X; Gu L; Yang K; Yang J; Hong T; Wei R Diabetes; 2023 May; 72(5):599-610. PubMed ID: 36826938 [TBL] [Abstract][Full Text] [Related]
5. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor. Longuet C; Robledo AM; Dean ED; Dai C; Ali S; McGuinness I; de Chavez V; Vuguin PM; Charron MJ; Powers AC; Drucker DJ Diabetes; 2013 Apr; 62(4):1196-205. PubMed ID: 23160527 [TBL] [Abstract][Full Text] [Related]
6. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells? Whalley NM; Pritchard LE; Smith DM; White A J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304 [TBL] [Abstract][Full Text] [Related]
7. Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis. Ali S; Lamont BJ; Charron MJ; Drucker DJ J Clin Invest; 2011 May; 121(5):1917-29. PubMed ID: 21540554 [TBL] [Abstract][Full Text] [Related]
8. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis. Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816 [TBL] [Abstract][Full Text] [Related]
10. Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor. Zhou C; Dhall D; Nissen NN; Chen CR; Yu R Pancreas; 2009 Nov; 38(8):941-6. PubMed ID: 19657311 [TBL] [Abstract][Full Text] [Related]
11. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214 [TBL] [Abstract][Full Text] [Related]
12. Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of ß-cell regeneration. Kilimnik G; Kim A; Steiner DF; Friedman TC; Hara M Islets; 2010; 2(3):149-55. PubMed ID: 20657753 [TBL] [Abstract][Full Text] [Related]
13. A switch from prohormone convertase (PC)-2 to PC1/3 expression in transplanted alpha-cells is accompanied by differential processing of proglucagon and improved glucose homeostasis in mice. Wideman RD; Covey SD; Webb GC; Drucker DJ; Kieffer TJ Diabetes; 2007 Nov; 56(11):2744-52. PubMed ID: 17698597 [TBL] [Abstract][Full Text] [Related]
14. Elevated Serum Amino Acids Induce a Subpopulation of Alpha Cells to Initiate Pancreatic Neuroendocrine Tumor Formation. Smith DK; Kates L; Durinck S; Patel N; Stawiski EW; Kljavin N; Foreman O; Sipos B; Solloway MJ; Allan BB; Peterson AS Cell Rep Med; 2020 Aug; 1(5):100058. PubMed ID: 33205067 [TBL] [Abstract][Full Text] [Related]
15. Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia. Rivero-Gutierrez B; Haller A; Holland J; Yates E; Khrisna R; Habegger K; Dimarchi R; D'Alessio D; Perez-Tilve D Mol Metab; 2018 Nov; 17():28-38. PubMed ID: 30170980 [TBL] [Abstract][Full Text] [Related]
16. Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells. Lee Y; Berglund ED; Yu X; Wang MY; Evans MR; Scherer PE; Holland WL; Charron MJ; Roth MG; Unger RH Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13217-22. PubMed ID: 25157166 [TBL] [Abstract][Full Text] [Related]
17. Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose. Zhang Y; Han C; Zhu W; Yang G; Peng X; Mehta S; Zhang J; Chen L; Liu Y Cells; 2021 Sep; 10(9):. PubMed ID: 34572144 [TBL] [Abstract][Full Text] [Related]
18. DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets. Hall E; Dayeh T; Kirkpatrick CL; Wollheim CB; Dekker Nitert M; Ling C BMC Med Genet; 2013 Jul; 14():76. PubMed ID: 23879380 [TBL] [Abstract][Full Text] [Related]